46 related articles for article (PubMed ID: 567804)
1. Evaluation of diastereomers of N-sec-butylnormorphine in a test of physical dependence.
Uyeno ET; DeGraw JI; Johnson HL; Lawson JA; Loew GH
Proc West Pharmacol Soc; 1978; 21():357-60. PubMed ID: 567804
[No Abstract] [Full Text] [Related]
2. Evaluation in nonhuman primates: evaluation of the physical dependence capacities of oripavine-thebaine partial agonists in patas monkeys.
Cowan A
Adv Biochem Psychopharmacol; 1973; 8(0):427-38. PubMed ID: 4211992
[No Abstract] [Full Text] [Related]
3. Quantitation of physical dependence in mice by naloxone-precipitated jumping after a single dose of morphine.
Smits SE
Res Commun Chem Pathol Pharmacol; 1975 Apr; 10(4):651-61. PubMed ID: 1171511
[TBL] [Abstract][Full Text] [Related]
4. The physical dependence liabilities of oxybutynin and morphine in rats.
Algate DR; Beard DJ
Arzneimittelforschung; 1985; 35(10):1577-9. PubMed ID: 4074417
[TBL] [Abstract][Full Text] [Related]
5. Potential usefulness of single-dose acute physical dependence on and tolerance to morphine for the evaluation of narcotic antagonists.
Jacob JJ; Barthelemy CD; Tremblay EC; Colombel MC
Adv Biochem Psychopharmacol; 1973; 8(0):299-318. PubMed ID: 4800176
[No Abstract] [Full Text] [Related]
6. Enkephalin analogs and physical dependence.
Wei ET
J Pharmacol Exp Ther; 1981 Jan; 216(1):12-8. PubMed ID: 7192734
[TBL] [Abstract][Full Text] [Related]
7. Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(-)-delta9-tetrahydrocannabinol.
Frederickson RC; Hewes CR; Aiken JW
J Pharmacol Exp Ther; 1976 Nov; 199(2):375-84. PubMed ID: 988178
[TBL] [Abstract][Full Text] [Related]
8. [Activity of naloxone and naltrexone on the development of the morphine withdrawal syndrome].
Piccinelli D; de Feo G; Mazzanti G
Boll Soc Ital Biol Sper; 1986 Oct; 62(10):1221-8. PubMed ID: 3828120
[No Abstract] [Full Text] [Related]
9. Dependence studies on new compounds in the rhesus monkey, rat and mouse (1989).
Aceto MD; Bowman ER; Harris LS; May EL
NIDA Res Monogr; 1989; 95():578-631. PubMed ID: 2641054
[No Abstract] [Full Text] [Related]
10. Acute opioid physical dependence in humans: naloxone dose response effects.
Heishman S; Stitzer M
NIDA Res Monogr; 1988; 81():195-201. PubMed ID: 3136361
[No Abstract] [Full Text] [Related]
11. Pharmacological adjuncts in the treatment of opiate dependence.
Resnick RB
Arch Invest Med (Mex); 1974; 5 SUPPL 1():235-44. PubMed ID: 4447422
[No Abstract] [Full Text] [Related]
12. Evidence against a role of brain 5-hydroxytryptamine in the development of physical dependence upon morphine in mice.
Marshall I; Grahame-Smith DG
J Pharmacol Exp Ther; 1971 Dec; 179(3):634-41. PubMed ID: 4257807
[No Abstract] [Full Text] [Related]
13. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
Windh RT; Little PJ; Kuhn CM
J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
[TBL] [Abstract][Full Text] [Related]
14. Blockade by narcotic drugs of naloxone-precipitated jumping in morphine-dependent mice.
Iorio LC; Deacon MA; Ryan EA
J Pharmacol Exp Ther; 1975 Jan; 192(1):58-63. PubMed ID: 1168251
[TBL] [Abstract][Full Text] [Related]
15. The substance P amino-terminal metabolite substance P(1-7), administered peripherally, prevents the development of acute morphine tolerance and attenuates the expression of withdrawal in mice.
Kreeger JS; Larson AA
J Pharmacol Exp Ther; 1996 Nov; 279(2):662-7. PubMed ID: 8930169
[TBL] [Abstract][Full Text] [Related]
16. Changes in succinic dehydrogenase activity in the central nervous system of mice during morphine dependence development, withdrawal and naloxone treatment.
Sood PP; Mohanakumar KP
Clin Physiol Biochem; 1985; 3(4):193-8. PubMed ID: 4040449
[TBL] [Abstract][Full Text] [Related]
17. Inhibition by adenosine analogs of opiate withdrawal effects.
Tucker JF; Plant NT; von Uexküll A; Collier HO
NIDA Res Monogr; 1984 Mar; 49():85-91. PubMed ID: 6090921
[TBL] [Abstract][Full Text] [Related]
18. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome.
Rehni AK; Bhateja P; Singh TG; Singh N
Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544
[TBL] [Abstract][Full Text] [Related]
19. Acute physical dependence in man: effects of naloxone after brief morphine exposure.
Bickel WK; Stitzer ML; Liebson IA; Bigelow GE
J Pharmacol Exp Ther; 1988 Jan; 244(1):126-32. PubMed ID: 3335995
[TBL] [Abstract][Full Text] [Related]
20. Morphine dependence and self-stimulation: attenuation of withdrawal-induced weight loss.
Glick SD; Marsanico RG; Zimmerberg B; Charap AD
Res Commun Chem Pathol Pharmacol; 1973 May; 5(3):725-32. PubMed ID: 4735638
[No Abstract] [Full Text] [Related]
[Next] [New Search]
